menu
    • menu
    [{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Otolaryngology (Ear, Nose, Throat)","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Carbon Dioxide","moa":"Undisclosed","graph1":"Otolaryngology (Ear, Nose, Throat)","graph2":"Phase II","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Otolaryngology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"Capnia","sponsor":"Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Carbon Dioxide","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II","graph3":"Capnia","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Capnia \/ Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center","highestDevelopmentStatusID":"8","companyTruncated":"Capnia \/ Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center"},{"orgOrder":0,"company":"Capnia","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Carbon Dioxide","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II","graph3":"Capnia","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Capnia \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Capnia \/ Undisclosed"},{"orgOrder":0,"company":"Capnia","sponsor":"Roger Cady","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Carbon Dioxide","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II","graph3":"Capnia","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Capnia \/ Roger Cady","highestDevelopmentStatusID":"8","companyTruncated":"Capnia \/ Roger Cady"}]

    Find Clinical Drug Pipeline Developments & Deals for Carbon Dioxide

    Menu

    Carbon Dioxide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Capnia

                            Country arrow
                            AAPS
                            Not Confirmed

                            Capnia

                            Country arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia

                            Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Trigeminal Neuralgia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            June 16, 2015

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Capnia

                            Country arrow
                            AAPS
                            Not Confirmed

                            Capnia

                            Country arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Roger Cady

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pilot Study Evaluating the Use of Nasal Carbon Dioxide for the Treatment of Cluster Headache

                            Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Cluster Headache.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 06, 2015

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Roger Cady

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            GSK

                            United Kingdom arrow
                            AAPS
                            Not Confirmed

                            GSK

                            United Kingdom arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Otolaryngology (Ear, Nose, Throat)

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Market Potential of Carbon Dioxide Nasal Spray

                            Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Nasal Obstruction.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            April 14, 2014

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Otolaryngology (Ear, Nose, Throat)

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Capnia

                            Country arrow
                            AAPS
                            Not Confirmed

                            Capnia

                            Country arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine

                            Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Migraine Disorders.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            December 06, 2010

                            Lead Product(s) : Carbon Dioxide

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth